Schmorl node (SN) is the herniation of the nucleus pulposus through the cartilaginous and bony endplate into the adjacent vertebral body. It is documented that SNs produce areas of moderately increased 18 F-FDG uptake. We present a case of a patient with history of neuroendocrine tumor, who underwent 68 Ga DOTATATE PET/CT for follow-up, showing increased focal vertebral uptake suggestive of bone metastasis. CT revealed typical findings of an SN. The presented case indicates that SNs should be considered when encountering focally increased skeletal uptake in 68 Ga DOTATATE PET/CT studies, which can mimic metastasis in patients with history of neuroendocrine tumors.
. A 73-year-old man with history of recurrent pancreatic neuroendocrine tumors underwent 68 Ga DOTATATE PET/CT study for follow-up. PET images showed focal increased 68 Ga DOTATATE uptake (SUV max , 6.39) at the level of T7 vertebral body (A, sagittal; B, axial 68 Ga DOTATATE fused PET/CT images), raising the suspicion of skeletal metastasis. CT bone window images revealed a radiolucent lesion (C, sagittal; D, axial CT images) in the body of T7 vertebra surrounded by osteosclerotic bone, in an otherwise intact vertebra. The adjacent endplate was disrupted with protrusion of disc material into the vertebral body, characteristic of a Schmorl node (SN). Consecutive spine CT scans were evaluated over a long period, showing stability of the lesion and no evidence of any other pathological process in the T7 vertebra. Schmorl nodes represent herniations of the nucleus pulposus of the intervertebral disc into the adjacent cartilaginous endplate of the vertebral body. 1, 2 There is no consensus regarding the pathogenesis of SNs. They are either considered as developmental defects due the abnormal persistence of vascular channels within the intervertebral disc, which result to weakening of the vertebral endplate, or SNs are perceived as the secondary result of subchondral osteonecrosis related to metabolic (osteoporosis, hyperparathyroidism), neoplastic, and degenerative disc disease or traumatic injury. Histological examination of en bloc slices through SNs has shown ischemic necrosis beneath the cartilaginous endplate, supporting the theory that SNs are secondary to osteonecrosis with disc components migrating into vertebral necrotic areas. [1] [2] [3] The reported in the literature prevalence of SNs in the general population ranges widely from 2% to 76%, with multiple lesions commonly found in the same individual. 4 Like in the presented case, it has been demonstrated that SNs appear more frequently in the T7 to L1 region, and most often (62.3%) affect the inferior surface of the vertebral body. 5 The majority of SNs are asymptomatic; however, in certain cases, it can be responsible for low back pain, especially in the presence of inflammatory changes and edema in the bone marrow. 6 Schmorl nodes most commonly do not show increased 18 F-FDG activity. However, it is reported that SNs can occasionally produce areas of moderately increased 18 F-FDG uptake, which is attributed to the inflammatory response induced by the protrusion of nucleus pulposus into the well-vascularized vertebral body and the contact of intraspongious disc material with the bone marrow. 7,8 68 Ga DOTATATE is a radiolabeled analog of somatostatin (SST) suitable for PET imaging with wide application in the diagnostic workup and follow-up of patients with neuroendocrine tumors because somatostatin receptors (SSTRs) are overexpressed by the majority of these tumors. [9] [10] [11] Furthermore, it has been documented that SSTRs are expressed and upregulated on white blood cells including leukocytes and macrophages, suggesting the potential role of PET/CT using 68 Ga DOTA-conjugated peptides (SST analogs) for imaging of inflammatory processes. [12] [13] [14] [15] The presented case indicates that inflammatory changes induced by the formation of an SN can result to increased 68 Ga DOTATATE activity, which has a predominant affinity for SSTR subtype 2 and should not be erroneously interpreted as sites of bone metastasis.
